ABL Bio Inc. (298380.KQ) KOE

187,500.00

+500(+0.27%)

Updated at December 24 03:30PM

Currency In KRW

Valuation

Market Cap1.44T
Enterprise Value1.42T
P/E Ratio-352.49
PEG Ratio12.58
Price/Sales Ratio105.5
Price/Book Ratio55.4
Enterprise/Revenue104.58
Enterprise/EBITDA-370.34

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.32
Operating Margin-0.34

Management Effectiveness

Return On Assets-0.12
Return On Equity-0.17

Income Statement

Revenue33.4B
Revenue/Share1,642.25
Gross Profit33.4B
EBITDA-53.15B
Net Income-55.53B
Diluted EPS-1,157.23

Balance Sheet

Total Cash127.2B
Total Cash/Share2,362.1
Total Debt43.48B
Total Debt/Equity0.24
Current Ratio2.53
Book Value Per Share3,383.75

Price History

52-Week Change559.05
52-Week High220,000
52-Week Low27,850
Moving Average 50 Days149,318
Moving Average 200 Days90,711

Statistics

Average Volume1.13M
Shares Outstanding49.76M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A